Vapotherm Inc Closes $20 Million Series C Financing Round - Gilde Healthcare

Vapotherm Inc Closes $20 Million Series C Financing Round

13. März 2015

EXETER, NH – Vapotherm, Inc., a developer and manufacturer of advanced respiratory care technology, today announced the closing of a $20MM equity financing. 3×5 Specialty Opportunity Fund led the financing round, which also included current investors QuestMark Partners, Gilde Healthcare Partners, Morgenthaler Ventures, Kaiser Permanente, Adage Capital Management, Crestline Investors and Cross Creek Capital.

Tony Arnerich General Partner of 3×5 Special Opportunity Fund commented: “We are excited about Vapotherm’s unique High Flow Therapy solution which improves clinical outcomes for patients with chronic and acute breathing disorders.”

“This new capital will be used to continue to build out our direct sales organization in the U.S. and to develop our next generation solutions. We appreciate the continued support of our investors as we build a leading respiratory care company,” said Joe Army, President and CEO of Vapotherm.

Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 700,000 patients have been treated with Vapotherm High Flow Therapy. For more information, visit www.vtherm.com.

Contact: John Landry, VP & CFO
T: (603) 658-0011

Gilde Healthcare Portfolio Company Big Health Adds Former FDA Deputy Commissioner Anand Shah to Its Board of Directors

Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced that it has added former Food and Drug Administration (FDA) Deputy Commissioner for Medical and Scientific Affairs Dr....
26. Januar 2022

Gilde Healthcare Portfolio Company Big Health Raises $75 Million in Series C Funding

Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced that it has raised $75 million in a Series C funding round, led by new investor SoftBank Vision...
19. Januar 2022

ProVerum raises €30M in Series A funding led by Gilde Healthcare & Lightstone Ventures

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor’s office, today announced the closing of a €30 million Series A equity financing led...
11. Januar 2022